Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this observational study is to evaluate the
incidence of adverse events while using Levemir® under normal clinical practice conditions.